Skip to main content
ESLA logo

ESLA · Estrella Immunopharma, Inc.

$0.72 -0.02 (-3.12%) At close · Aug 7
Market Cap
$31.09M
Shares
43.03M

Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.

Short Volume

Date Short Volume Short Exempt Total Volume Short %
2026-08-07 844 0 2,074 40.7%
2026-08-06 1,890 50 6,978 27.1%
2026-08-05 25,113 0 42,813 58.7%
2026-08-04 4,536 0 8,200 55.3%
2026-08-03 2,518 0 8,461 29.8%
2026-07-31 721 0 3,586 20.1%
2026-07-30 3,796 0 24,300 15.6%
2026-07-29 1,981 0 4,519 43.8%
2026-07-28 975 100 19,537 5.0%
2026-07-27 1,277 0 8,811 14.5%
2026-07-24 18,543 0 41,144 45.1%
2026-07-23 2,784 0 5,549 50.2%
2026-07-22 2,746 0 4,121 66.6%
2026-07-21 3,908 0 17,067 22.9%
2026-07-20 16,848 0 52,329 32.2%
2026-07-17 40,402 109 146,296 27.6%
2026-07-16 3,540 0 6,869 51.5%
2026-07-15 16,166 0 22,858 70.7%
2026-07-14 5,230 0 24,795 21.1%
2026-07-13 7,230 0 14,929 48.4%
2026-07-10 12,477 0 30,771 40.5%
2026-07-09 9,348 0 29,383 31.8%
2026-07-08 674 15 5,096 13.2%
2026-07-07 1,038 301 19,740 5.3%
2026-07-06 8,688 0 24,789 35.0%
2026-07-02 1,130 0 7,769 14.5%
2026-07-01 2,359 0 126,686 1.9%
2026-06-30 4,949 80 13,818 35.8%
2026-06-29 9,586 0 11,410 84.0%
2026-06-26 7,083 0 14,101 50.2%
2026-06-25 6,071 0 18,150 33.4%
2026-06-24 10,954 0 26,201 41.8%
2026-06-23 15,411 0 26,439 58.3%
2026-06-22 13,536 0 25,762 52.5%
2026-06-18 5,509 0 8,054 68.4%
2026-06-17 1,428 0 5,257 27.2%
2026-06-16 5,725 2,000 20,989 27.3%
2026-06-15 10,498 0 16,194 64.8%
2026-06-12 3,956 78 12,885 30.7%
2026-06-11 14,112 0 25,040 56.4%
2026-06-10 8,312 0 22,453 37.0%
2026-06-09 8,491 4,578 23,341 36.4%
2026-06-08 17,422 3,914 46,623 37.4%
2026-06-05 834 0 4,444 18.8%
2026-06-04 121,247 0 140,247 86.5%
2026-06-03 17,523 0 35,657 49.1%
2026-06-02 879 0 4,069 21.6%
2026-06-01 17,402 0 34,858 49.9%
2026-05-29 2,537 0 6,299 40.3%
2026-05-28 7,989 0 22,270 35.9%
Showing 1–50 of 62 days
Key facts CIK 1844417 CUSIP 297584104 13F (30d) 3 filings 3 filers Visit website Investor relations